Companies ›Consumer Non Cyclicals ›2429.HK

2429.HK — HKEX Food Retail & Distribution

2429.Hk

HK$2,18

Open in Charts → Attach watcher ⌖

— —

HKD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

-2,7 %

ROE

-5,8 %

Net margin

-2,5 %

Debt / equity

0,07

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.

Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryFood Retail & Distribution

ActivityFood & Drug Retailing

Generated · model-assisted

Sell-side consensus

—consensus pending

— buy— hold— sell

Avg 12m price target—

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts

—

not yet wired

Ownership

—

not yet wired

Profitability→

-5,8 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning 2429.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to 2429.HK. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

The company operates in the Food & Drug Retailing sector, generating revenue primarily through the retail sale of food and drug products.

Classification92 %

SectorConsumer Non-Cyclicals

Business sectorFood & Drug Retailing

IndustryFood Retail & Distribution

ActivityFood & Drug Retailing

AI synthesis

GENERATED

The company maintains a strong liquidity position, with a current ratio of 2.33, indicating that it has more than twice the current assets to cover its current liabilities. Its cash and equivalents amount to CNY 705.8 million, which is a significant portion of its total assets of CNY 1.74 billion. The debt-to-equity ratio is low at 0.07, suggesting that the company is not heavily leveraged and has a conservative capital structure.

Profitability is a concern, as the company reported a net loss of CNY 68.7 million and an operating loss of CNY 75.5 million in the latest period. The return on equity is negative at -5.82%, and the return on assets is also negative at -3.95%, indicating that the company is not generating returns that exceed its cost of capital. These figures are below the industry median for profitability metrics, suggesting underperformance relative to its peers.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks, particularly in the event of regional economic downturns or supply chain disruptions.

Looking ahead, the company's growth trajectory is uncertain. There are no specific numeric deltas provided for the current or next fiscal year, but the reported operating and net losses suggest that the company may face challenges in achieving revenue growth in the near term. The company's historical performance indicates a need for strategic adjustments to improve profitability and operational efficiency.

The risk assessment indicates that the company has low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. However, the company's negative net income and operating income suggest that it may need to consider additional financing options in the future, which could lead to potential dilution for shareholders. The company has not disclosed any recent share issuance or dilution events, and there are no indications of near-term pressure for further dilution.

Recent events, as disclosed in the latest financial filings, do not include any significant corporate actions or strategic initiatives that would impact the company's financial position or operational performance. The company has not issued any new products or entered into major partnerships that would alter its competitive landscape or revenue streams.

Key takeaways

The company has a strong liquidity position with a current ratio of 2.33 and significant cash reserves.
Profitability is a major concern, with negative returns on equity and assets.
The company's revenue is not diversified across segments or geographies, increasing operational risk.
There are no immediate liquidity or dilution risks, but the company may need to seek additional financing in the future.
Recent events do not indicate any strategic changes or new initiatives that would impact the company's financial performance.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

HK$2,18

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

HK$1.18B

Net cashⓘ

HK$627.4M

Current ratioⓘ

2.3

Debt / equityⓘ

0.1

ROAⓘ

-4.0%

ROEⓘ

-5.8%

Cash conversionⓘ

—

CapEx / revenueⓘ

—

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

— missing data

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskLow

Filing-based flags

No immediate filing-based liquidity or dilution flags were detected.

Benchmarks vs cohort

Op Margin-2,7 %Bottom quartile

Net Margin-2,5 %Bottom quartile

ROE-5,8 %Bottom quartile

D/E0,07Above P75

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Return On Assets
net_income / total_assets

Source documents

2429.HK Market data — financials · 2026-05-26

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

2429.HKCanonical

HKEX · HKD

Intel & risk

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskLow

No immediate filing-based liquidity or dilution flags were detected.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

— missing data

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread